Drug laws and licensing
Reports, Advice & Correspondence
The Advisory Council produces considered reports that will be helpful to policy makers, practitioners, service providers and others.
Drug specific reports
The Advisory Council carries out in-depth reviews of specific drugs, including their classification under the Misuse of Drugs Act 1971.
The most recent drug specific reports published by the Advisory Council are:
- ACMD report on the cannabinoid agonists
- ACMD 1-benzylpiperazine (BZP) Report (2008)
- GBL & 1,4-BD: Assessment of Risk to the Individual and Communities in the UK (2008)
- MDMA (‘ecstasy’): a review of its harms and classification under the Misuse of Drugs Act 1971 (2009)
- Cannabis Classification and Public Health (2008)
Inquiry reports
The Advisory Council, through its Prevention Working Group, carries out in-depth inquiries into aspects of drug use that are causing particular concern in the UK, with the aim of producing considered Reports that will be helpful to policy makers, practitioners, service providers and others.
These inquiry reports set out a summary of the Advisory Council’s findings and a series of recommendations for Government and others. It is usual for the government to then publish a formal response.
The most recent inquiry reports published by the Advisory Council are:
Correspondence
Consultation Responses
Annual reports
Annual reports from the Advisory Council detailing the main issues considered by its committees and working groups. They also include information about the Advisory Council's terms of reference, membership and administration arrangements.
